C46.5
Kaposi's sarcoma of lung
Clinical Classification Guidelines
Medical Intelligence & Overview
Kaposi's sarcoma of the lung is a rare type of cancer that affects the lung tissues. It is part of a group of cancers known as Kaposi's sarcoma, characterized by the abnormal growth of blood vessels, which can form tumors in various parts of the body. This particular form impacts the lungs, often complicating diagnosis and treatment. While it is more common in individuals with compromised immune systems, such as those with HIV/AIDS, it can also occur in other contexts. Recognizing the signs and understanding the causes and options for managing this condition are vital steps toward appropriate healthcare intervention.
Causes & Symptoms
Clinical Causes: Infection with Human Herpesvirus 8 (HHV-8): The primary cause linked to Kaposi’s sarcoma is infection with HHV-8, which promotes abnormal blood vessel growth. Immune system suppression: Conditions that weaken immune response, such as HIV/AIDS, increase the risk of developing Kaposi's sarcoma. Immunosuppressive therapy: Patients undergoing immunosuppressive treatments after organ transplants may be more susceptible. Genetic factors: Certain genetic predispositions might contribute to an elevated risk, especially in cases not related to immune suppression. Environmental factors: Although less clear, exposure to certain environmental elements may influence risk in predisposed individuals.
Key Symptoms: Persistent cough or shortness of breath Chest pain or discomfort Coughing up blood (hemoptysis) Unexplained weight loss Fatigue or weakness Fever and night sweats Feeling of chest fullness or pressure
Diagnostic & Treatment
Diagnosis Path: Diagnosing Kaposi's sarcoma of the lung involves a combination of medical history assessment, physical examination, and imaging tests. Common procedures include:
Treatment Protocols: Treatment options for Kaposi's sarcoma of the lung are tailored to individual patient circumstances and disease extent. They may include:
Clinical Advice & FAQs
Billing Guidance
Is C46.5 a billable ICD-10 code?
Yes, C46.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C46.5?
Clinical documentation must specify the nature of Kaposi's sarcoma of lung and any associated comorbidities for accurate reporting.
Cite this Clinical Reference